BR9607663A - Uso de penciclovir para o tratamento de herpes-virus 8 humano - Google Patents

Uso de penciclovir para o tratamento de herpes-virus 8 humano

Info

Publication number
BR9607663A
BR9607663A BR9607663A BR9607663A BR9607663A BR 9607663 A BR9607663 A BR 9607663A BR 9607663 A BR9607663 A BR 9607663A BR 9607663 A BR9607663 A BR 9607663A BR 9607663 A BR9607663 A BR 9607663A
Authority
BR
Brazil
Prior art keywords
treatment
penciclovir
herpes virus
human herpes
bioprecursor
Prior art date
Application number
BR9607663A
Other languages
English (en)
Inventor
Richard Anthony Vere Hodge
Klaus Max Esser
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Publication of BR9607663A publication Critical patent/BR9607663A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9607663A 1995-03-07 1996-03-05 Uso de penciclovir para o tratamento de herpes-virus 8 humano BR9607663A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504497.0A GB9504497D0 (en) 1995-03-07 1995-03-07 Pharmaceuticals
PCT/EP1996/000933 WO1996027378A2 (en) 1995-03-07 1996-03-05 Use of penciclovir for the treatment of human herpes-virus-8

Publications (1)

Publication Number Publication Date
BR9607663A true BR9607663A (pt) 1998-06-16

Family

ID=10770731

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9607663A BR9607663A (pt) 1995-03-07 1996-03-05 Uso de penciclovir para o tratamento de herpes-virus 8 humano

Country Status (23)

Country Link
US (1) US6489330B1 (pt)
EP (1) EP0814813B1 (pt)
JP (2) JPH11501625A (pt)
KR (1) KR19980702833A (pt)
CN (1) CN1138545C (pt)
AT (1) ATE254919T1 (pt)
AU (1) AU701739B2 (pt)
BR (1) BR9607663A (pt)
CA (1) CA2214406C (pt)
CY (1) CY2525B1 (pt)
CZ (1) CZ293470B6 (pt)
DE (1) DE69630876T2 (pt)
DK (1) DK0814813T3 (pt)
ES (1) ES2211949T3 (pt)
GB (1) GB9504497D0 (pt)
HK (1) HK1004373A1 (pt)
HU (1) HU226005B1 (pt)
NO (1) NO317733B1 (pt)
NZ (1) NZ303951A (pt)
PT (1) PT814813E (pt)
TR (1) TR199700921T1 (pt)
WO (1) WO1996027378A2 (pt)
ZA (1) ZA961795B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2721148A1 (en) * 2008-04-11 2009-10-15 Epiphany Biosciences, Inc. Treatment and/or prevention of multiple sclerosis
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
EP0216459B1 (en) * 1985-07-27 1990-05-16 Beecham Group Plc 9-substituted guanine monohydrates
CA2042931A1 (en) 1990-05-24 1991-11-25 Robert Zahler Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
PT814813E (pt) 2004-04-30
HUP9800272A3 (en) 2000-12-28
DE69630876T2 (de) 2004-09-02
ES2211949T3 (es) 2004-07-16
CA2214406C (en) 2010-12-21
HUP9800272A2 (hu) 2000-05-28
EP0814813B1 (en) 2003-11-26
EP0814813A2 (en) 1998-01-07
JP2007297412A (ja) 2007-11-15
NZ303951A (en) 1999-07-29
CY2525B1 (en) 2006-02-08
NO317733B1 (no) 2004-12-13
TR199700921T1 (xx) 1998-02-21
CZ283197A3 (cs) 1998-02-18
KR19980702833A (ko) 1998-08-05
HU226005B1 (en) 2008-02-28
GB9504497D0 (en) 1995-04-26
CZ293470B6 (cs) 2004-05-12
HK1004373A1 (en) 1998-11-27
MX9706759A (es) 1997-11-29
WO1996027378A2 (en) 1996-09-12
DE69630876D1 (de) 2004-01-08
US6489330B1 (en) 2002-12-03
DK0814813T3 (da) 2004-03-22
WO1996027378A3 (en) 1997-01-16
AU5102296A (en) 1996-09-23
JPH11501625A (ja) 1999-02-09
ZA961795B (en) 1996-11-25
AU701739B2 (en) 1999-02-04
ATE254919T1 (de) 2003-12-15
NO974101D0 (no) 1997-09-05
CA2214406A1 (en) 1996-09-12
CN1183722A (zh) 1998-06-03
NO974101L (no) 1997-09-05
CN1138545C (zh) 2004-02-18

Similar Documents

Publication Publication Date Title
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
CA2207503A1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections
ES2169117T3 (es) Uso de derivados de 2-aminopurina en el tratamiento y profilaxis de la infeccion por el virus 7 del herpes humano.
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
CY2338B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections.
ES2124926T3 (es) Uso de desoxipergualina para la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias e hiperreactivas.
DK0674645T3 (da) Cephemforbindelser med antimikrobiel virkning

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
B25A Requested transfer of rights approved

Free format text: SMITHKLINE BEECHAM CORPORATION (US), NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, DE ACORDO COM OS ARTIGOS 11,13 E 8 DA LPI, LEI DE NUMERO 9.279 DE 14 DE MAIO DE 1996.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/522 (2006.01)